Major depressive disorder
Major depressive disorder (MDD) is characterized by persistent depressed mood, loss of
interest or pleasure in previously enjoyable activities, recurrent thoughts of death, and
interest or pleasure in previously enjoyable activities, recurrent thoughts of death, and
Acylcarnitines: nomenclature, biomarkers, therapeutic potential, drug targets, and clinical trials
M Dambrova, M Makrecka-Kuka, J Kuka - Pharmacological , 2022 - Elsevier
Acylcarnitines are fatty acid metabolites that play important roles in many cellular energy
metabolism pathways. They have historically been used as important diagnostic markers for
metabolism pathways. They have historically been used as important diagnostic markers for
Digital era 4.0: The contribution to education and student psychology
This study aims to explain the challenges of teachers in the digital era 4.0 and readiness to
face these challenges. Through literature review. The author explains that there are several
face these challenges. Through literature review. The author explains that there are several
Treatmentresistant depression: definition, prevalence, detection, management, and investigational interventions
Treatmentresistant depression (TRD) is common and associated with multiple serious
public health implications. A consensus definition of TRD with demonstrated predictive utility
public health implications. A consensus definition of TRD with demonstrated predictive utility
[HTML][HTML] Treatment resistance in psychiatry: state of the art and new directions
OD Howes, ME Thase, T Pillinger - Molecular psychiatry, 2022 - nature.com
Abstract Treatment resistance affects 20–60% of patients with psychiatric disorders; and is
associated with increased healthcare burden and costs up to ten-fold higher relative to
associated with increased healthcare burden and costs up to ten-fold higher relative to
A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials
L Sforzini, C Worrell, M Kose, IM Anderson - Molecular , 2022 - nature.com
Criteria for treatment-resistant depression (TRD) and partially responsive depression (PRD)
as subtypes of major depressive disorder (MDD) are not unequivocally defined. In the
as subtypes of major depressive disorder (MDD) are not unequivocally defined. In the
Comparative efficacy of racemic ketamine and esketamine for depression: a systematic review and meta-analysis
Background Ketamine appears to have a therapeutic role in certain mental disorders, most
notably depression. However, the comparative performance of different formulations of
notably depression. However, the comparative performance of different formulations of
Efficacy and safety of fixed-dose esketamine nasal spray combined with a new oral antidepressant in treatment-resistant depression: results of a randomized, double
M Fedgchin, M Trivedi, EJ Daly - International Journal , 2019 - academic.oup.com
Background About one-third of patients with depression fail to achieve remission despite
treatment with multiple antidepressants and are considered to have treatment-resistant
treatment with multiple antidepressants and are considered to have treatment-resistant
Depression in the primary care setting
LT Park, CA Zarate Jr - New England Journal of Medicine, 2019 - Mass Medical Soc
Key Clinical Points Depression in the Primary Care Setting Screening for depression and
suicidal thinking and behavior is important in the primary care setting. Distinguishing
suicidal thinking and behavior is important in the primary care setting. Distinguishing
Ketamine for the acute treatment of severe suicidal ideation: double blind, randomised placebo controlled trial
Objective To confirm the rapid onset anti-suicidal benefits of ketamine in the short term and
at six weeks, overall and according to diagnostic group. Design Prospective, double blind
at six weeks, overall and according to diagnostic group. Design Prospective, double blind